- ICU Medical press release ( NASDAQ: ICUI ): Q4 Non-GAAP EPS of $1.60 beats by $0.04 .
- Revenue of $578.01M (+69.7% Y/Y) misses by $4.92M .
- 2023 Guidance: For Fiscal Year 2023 the Company estimates GAAP net loss to be in the range of $(73) to $(37) and GAAP diluted loss per share estimated to be in the range of $(3.00) to $(1.50). For the Fiscal Year 2023, the Company expects adjusted EBITDA to be in the range of $375 million to $425 million, and adjusted diluted EPS to be in the range of $5.75 to $7.25.
For further details see:
ICU Medical Non-GAAP EPS of $1.60 beats by $0.04, revenue of $578.01M misses by $4.92M